Bośnia i Hercegowina - chorwacki - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pfizer bh d.o.o. sarajevo - temsirolimus - koncentrat i razrjeđivač za otopinu za infuziju - 30 mg/1 bočica - 1 bočica sa 1,2 ml koncentrata za otopinu za infuziju sadrži: 30 mg temsirolimusa

Unia Europejska - słoweński - EMA (European Medicines Agency)

pfizer europe ma eeig - sirolimus - graft rejection; kidney transplantation - imunosupresivi - zdravilo rapamune je indicirano za profilakso zavrnitve organa pri odraslih bolnikih z majhnim do zmernim imunskim tveganjem, ki prejemajo presaditev ledvic. priporočljivo je, da rapamune uporablja sprva v kombinaciji z ciclosporin microemulsion in kortikosteroidi za 2 do 3 mesece. rapamune lahko nadaljeval, kot vzdrževalna terapija s kortikosteroidi le, če ciclosporin microemulsion lahko postopno opuščeni. rapamune je indiciran za zdravljenje bolnikov z občasno lymphangioleiomyomatosis z zmerno boleznijo pljuč ali upada pljučne funkcije.

Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商惠氏藥廠（亞洲）股份有限公司台灣分公司 台北市信義區松仁路100號42、43樓 (23984410) - sirolimus nanosystems dispersion - 糖衣錠 - 主成分 (active filler coat：) ; sirolimus nanosystems dispersion (9200039620) sirolimus 100% 2mg,poloxamer 188 1 mgmg - sirolimus - 1.與cyclosporine及皮質類固醇合併使用來預防病人腎臟移植後之器官排斥。2.若病人有低度或中度免疫上的危險於移植後2到4個月，可以逐步停止使用cyclosporine而斥消靈 (sirolimus)應增加劑量至到達血中建議濃度。

Tajwan - chiński - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商惠氏藥廠（亞洲）股份有限公司台灣分公司 台北市信義區松仁路100號42、43樓 (23984410) - sirolimus nanosystems dispersion;;sirolimus - 糖衣錠 - 主成分 (active filler coat：) ; sirolimus nanosystems dispersion (9200039620) (150mg/g)mg; sirolimus (9200039600) 100%mg - sirolimus - １、適用於與cyclosporine及皮質類固醇合併使用來預防病人腎臟移植後之器官排斥。２、適用於淋巴血管平滑肌增生症(lymphangioleiomyomatosis，簡稱lam)成人病人的治療。

Unia Europejska - angielski - EMA (European Medicines Agency)

pfizer europe ma eeig - temsirolimus - carcinoma, renal cell; lymphoma, mantle-cell - antineoplastic agents - renal-cell carcinomatorisel is indicated for the first-line treatment of adult patients with advanced renal-cell carcinoma (rcc) who have at least three of six prognostic risk factors.mantle-cell lymphomatorisel is indicated for the treatment of adult patients with relapsed and / or refractory mantle-cell lymphoma (mcl).

Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sirolimus 1 mg/ml;   - oral solution - 1 mg/ml - active: sirolimus 1 mg/ml   excipient: phosal 50 pg polysorbate 80 - rapamune is indicated for the prophylaxis of organ rejection in patients at mild to moderate immunological risk receiving renal transplants. therapeutic drug monitoring of sirolimus is required.

Unia Europejska - niderlandzki - EMA (European Medicines Agency)

plusultra pharma gmbh - sirolimus - angiofibroma; tuberous sclerosis - hyftor is indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex in adults and paediatric patients aged 6 years and older.

Węgry - węgierski - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

accord healthcare polska sp. z o.o. - temszirolimusszal -

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - sirolimusum - soluzione orale - sirolimusum 1 mg, polysorbatum 80, phosphatidylcholinum, sojae olio 20 mg, mono/diglycerida, ethanolum il 96 per cento 20 mg, propylenglycolum 350 mg, e 304, per la soluzione 1 ml, ethanolum 3.17 % v/v. - immunsuppressivum - biotechnologika

Szwajcaria - włoski - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - sirolimusum - compresse rivestite - sirolimusum 1 mg, poloxamerum 188, lactosum monohydricum 86.4 mg, macrogolum 8000, magnesio stearas, talco, macrogolum 20'000, glyceroli mono-oleas, lacca, calcio sulfas anhydricus, cellulosum microcristallinum, sintetico 213.85 mg, e 171, povidonum k 29-32, int-rac-alfa-tocopherylis acetas, cera carnauba, drucktinte: lacca, e 172 (rosso), propylenglycolum, simeticonum, per compresso haze. - immunsuppressivum - biotechnologika